成瘾治疗市场规模、份额、成长分析、按类型、按药物类型、按治疗中心、按分销管道、按地区 - 行业预测，2024-2031 年

2022年全球成瘾治疗市场规模将为51亿美元，从2023年的54亿美元成长到2031年的84.7亿美元，在预测期内（2024-2031年）预计复合年增长率为5.80%。

由于成瘾率上升、毒品意识提升增强、预防计划和技术进步等多种因素的综合作用，成瘾治疗市场正在经历显着扩张。政府的支持和宣传宣传活动正在鼓励更多的人寻求治疗，透过各种媒体管道提供的资讯也是如此。随着受成瘾影响的人口增加，新药物和治疗设施（特别是私人康復中心）的出现正在扩大获得治疗的机会。市场成长的一个显着因素是全球处方药滥用的快速增加。政府的支持措施，例如宣传计划和戒烟治疗的有利报销政策，进一步支持了市场动态。治疗方法和药物方面不断的技术创新，以及大众对成瘾问题的认识不断提高，也支持了市场的扩张。 Cipla Inc.、Alkermes 和 Pfizer Inc. 等领先公司正在透过合併和合作伙伴关係对创新解决方案进行策略性投资。该市场涵盖多种治疗类别，包括酒精、烟草和鸦片类药物成瘾，其中由于人们对其健康影响的认识不断增强，烟草治疗预计将增长最快。此外，无线技术在治疗设施中变得越来越普遍，復健中心在整体护理方法方面处于市场领先地位。在药物滥用增加、中阶不断壮大以及政府努力加强医疗保健的推动下，亚太地区预计将出现最高的成长。然而，挑战仍然存在，特别是治疗过程漫长，需要持续监测和多重干预，这可能会阻碍未来的市场成长。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 市场生态系统
• 案例研究分析
• 监管环境
• 创新矩阵
• 重点投资分析
• 关键成功因素
• 竞争程度

成瘾治疗市场：按类型

• 市场概况
• 酒精成瘾治疗
• 烟草/尼古丁成瘾治疗
• 阿片类药物成瘾治疗
• 其他的

成瘾治疗市场：按药物类型

• 市场概况
• 安非他酮
• Varenicline
• Acamprosate
• Disulfiram
• 纳曲酮
• 美沙酮
• Buprenornhine
• 尼古丁替代产品
• 其他的

成瘾治疗市场：依治疗中心分类

• 市场概况
• 住宅治疗中心
• 门诊治疗中心
• 住院治疗中心

成瘾治疗市场：依通路分类

• 市场概况
• 零售药房
• 医院药房
• 网路药房

成瘾治疗市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Alkermes plc（Ireland）
• Dr. Reddy's Laboratories Ltd.（India）
• Hikma Pharmaceuticals plc（UK）
• Indivior PLC（UK）
• Mallinckrodt Pharmaceuticals（Ireland）
• Orexo AB（Sweden）
• Pear Therapeutics（US）Inc.（US）
• Pfizer Inc.（US）
• Viatris Inc.（US）
• American Addiction Centers, Inc.（US）
• Quest Diagnostics, Inc.（US）
• Sage Therapeutics, Inc.（US）
• Gilead Sciences, Inc.（US）
• Acadia Pharmaceuticals Inc.（US）
• Medications for Addiction Treatment（MAT）（US）
• Intra-Cellular Therapies, Inc.（US）
• Emergent BioSolutions Inc.（US）
• Hims & Hers Health, Inc.（US）
• Lundbeck A/S（Denmark）
• Cambrex Corporation（US）
• Caron Treatment Centers（US）
• Smart Recovery（US）
• Recovery Brands（US）

Global Addiction Treatment Market size was valued at USD 5.1 billion in 2022 and is poised to grow from USD 5.4 billion in 2023 to USD 8.47 billion by 2031, growing at a CAGR of 5.80% during the forecast period (2024-2031).

The addiction treatment market is witnessing significant expansion driven by a confluence of factors, including rising addiction rates, enhanced drug awareness initiatives, preventive programs, and technological advancements. Government backing and awareness campaigns are prompting more individuals to pursue treatment, bolstered by the availability of information across various media. The emergence of new medications and treatment facilities-especially private recovery centers-has broadened access to care for an increasing population impacted by addiction. A notable contributor to market growth is the global surge in prescription medication misuse. Supportive government measures, including awareness programs and favorable reimbursement policies for smoking cessation therapies, are propelling market dynamics further. Continuous innovation in therapies and medications also promises to fuel expansion, alongside a growing public awareness of addiction issues. Major players like Cipla Inc., Alkermes, and Pfizer Inc. are strategically investing in innovative solutions through mergers and partnerships. The market encapsulates different treatment categories, such as alcohol, tobacco, and opioid addiction, with tobacco treatment poised for the most rapid growth due to heightened awareness of its health impacts. Moreover, wireless addiction treatment technologies are gaining traction within treatment facilities, with rehabilitation centers leading the way due to their holistic care methodologies. The Asia-Pacific region is anticipated to experience the highest growth, driven by increasing substance abuse, an expanding middle class, and governmental efforts to enhance healthcare access. Nonetheless, challenges remain, particularly concerning the lengthy nature of treatment processes that require ongoing monitoring and multiple interventions, which may inhibit future market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the global addiction treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global addiction treatment Market Segmental Analysis

Global Addiction Treatment Market is segmented by Type, Drug Type, Treatment Centers, Distribution Channel, and region. Based on Type, the market is segmented into Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, and Others. Based on Drug Type, the market is segmented into Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, Others. Based on Treatment Centers, the market is segmented into Residential Treatment Centers, Outpatient Treatment Centers, and Inpatient Treatment Centers. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global addiction treatment Market

The rising prevalence of substance abuse disorders globally is a significant market driver for the addiction treatment market. Increasing awareness about the health and social consequences of addiction is prompting more individuals to seek help, thereby boosting demand for various treatment options, including rehabilitation programs, counseling, and medication-assisted therapies. Additionally, the growing acceptance of mental health issues and the reduction of stigma surrounding addiction are fostering a supportive environment for those in need of treatment. This trend, coupled with advancements in therapeutic techniques and supportive digital platforms, is expected to drive the growth of the global addiction treatment market significantly.

Restraints in the global addiction treatment Market

The global addiction treatment market is likely to encounter significant restraints that may hinder its growth trajectory. The increasing legalization and widespread use of cannabis could lead to a misconception that substance abuse is less severe, potentially reducing demand for traditional addiction treatments. Furthermore, the expiration of patents for key pharmaceutical treatments may result in a rise in generic alternatives, affecting profitability for established companies in the sector. Additionally, the advancement of medical devices specifically designed for opioid addiction treatments may divert interest and resources from conventional therapies, further complicating the market landscape and stalling overall development and investment in addiction treatment solutions.

Market Trends of the global addiction treatment Market

The global addiction treatment market is increasingly shifting towards holistic and personalized care models, reflecting a broader understanding of addiction as a multifaceted issue that encompasses physical, mental, and social dimensions. This evolving market trend sees rehabilitation centers implementing tailored treatment plans that address individual patient needs, providing comprehensive support systems extending beyond traditional therapy and into aftercare. The integration of mental health services, community support, and innovative therapeutic options is enhancing accessibility and effectiveness of treatment. As a result, the sector is experiencing growth driven by a commitment to delivering well-rounded care that promotes lasting recovery and improved quality of life for individuals.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Case study Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Addiction Treatment Market by Type

• Market Overview
• Alcohol Addiction Treatment
• Tobacco/Nicotine Addiction Treatment
• Opioid Addiction Treatment
• Others

Addiction Treatment Market by Drug Type

• Market Overview
• Bupropion
• Varenicline
• Acamprosate
• Disulfiram
• Naltrexone
• Methadone
• Buprenorphine
• Nicotine Replacement Products
• Others

Addiction Treatment Market by Treatment Centers

• Market Overview
• Residential Treatment Centers
• Outpatient Treatment Centers
• Inpatient Treatment Centers

Addiction Treatment Market by Distribution Channel

• Market Overview
• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

Addiction Treatment Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Alkermes plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indivior PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orexo AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pear Therapeutics (US) Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Addiction Centers, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sage Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acadia Pharmaceuticals Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medications for Addiction Treatment (MAT) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intra-Cellular Therapies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hims & Hers Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lundbeck A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caron Treatment Centers (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smart Recovery (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recovery Brands (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments